About: http://data.cimple.eu/news-article/cd946f7fb0f14ba8b2b766572377c492234fcadb8f5c7fc849d9d600

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/cd946f7fb0f14ba8b2b766572377c492234fcadb8f5c7fc849d9d600 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Australia approved the anti-viral drug remdesivir for treatment of COVID-19 Friday following a similar decision from the European Commission. It is the first drug approved by Australian authorities to treat the virus and promised to reduce hospitalisation time for coronavirus patients, Australia's Therapeutic Goods Administration(TGA) said in a statement. "By reducing recovery times, patients will be able to leave hospital earlier, freeing beds for those in need," the TGA said. The drug was given provisional approval for adults and adolescent patients and would be limited to those severely unwell from the virus, needing help to breathe and in hospital care, the authority noted. "While this is a major milestone in Australia's struggle against the pandemic, it is important to emphasise that the product has not been shown to prevent coronavirus infection or relieve milder cases of infection." The decision comes after the EU's executive arm cleared the drug -- which was originally intended as a treatment for Ebola -- for use while Washington bought up almost all supplies. Recently the US said it had purchased 92 percent of all remdesivir from its producer, Gilead Sciences, until the end of September -- about 500,000 treatments out of nearly 550,000. Several other Asian nations have also approved the drug for treatment against COVID-19. Australia's call to approve the drug was made on "preliminary clinical data" and aided by reports from the EU's European Medicines Agency and Singapore's Health Sciences Authority. al/rma
schema:headline	Australia approves remdesivir as virus treatment
schema:mentions	Unwell European Commission Therapeutic Goods Administration European Medicines Agency Antiviral drug Remdesivir Asia Ebola virus disease Singapore George Washington Australia European Union Pandemic Severe acute respiratory syndrome coronavirus 2 Health Sciences Authority Gilead Sciences Qiang language
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-07-10 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	86 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software